Udrota P 80mg/325mg Tablet
Marketer
Yodley Life Sciences Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (325mg)
Overview Udrota P 80mg/325mg Tablet
Combiflam P 80mg/325mg tablets offer relief from abdominal pain. This combination medication effectively alleviates abdominal pain, bloating, discomfort, and cramping by relaxing the gastrointestinal tract's muscles and inhibiting pain-inducing chemical signals. Always follow your physician's instructions regarding dosage and duration, taking the medication with food. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence or condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects, often temporary, include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Consult your doctor before use if pregnant, planning pregnancy, breastfeeding, or if you have kidney or liver conditions to ensure appropriate dosage.
Primary Ingredients of Udrota P 80mg/325mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Udrota P 80mg/325mg Tablet
Managing abdominal discomfort
Major Benefits of Udrota P 80mg/325mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Udrota P 80mg/325mg tablet should be administered with a meal.
Common Side effects of Udrota P 80mg/325mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Udrota P 80mg/325mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without crushing, chewing, or breaking it. The Udrota P 80mg/325mg Tablet should be taken with a meal.
How Udrota P 80mg/325mg Tablet works:
Each Udrota P 80mg/325mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory chemicals responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Udrota P 80mg/325mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Udrota P 80mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Udrota P 80mg/325mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Udrota P 80mg/325mg tablets might lead to adverse reactions that impair driving capabilities, including dizziness.
KidneyCAUTION
Patients with kidney impairment should use the 80mg/325mg Udrota P tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. Udrota P 80mg/325mg tablets are contraindicated for those with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Udrota P 80mg/325mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Udrota P 80mg/325mg Tablet :
Should you forget to take a Udrota P 80mg/325mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Udrota P 80mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently